Metastatic bone pain: treatment options with an emphasis on bisphosphonates

[1] Anselmetti GC(2005)Treatment of painful compression vertebral fractures with vertebroplasty: results and complications Radiol Med (Torino) 110 262-272

[2] Corgnier A(2003)Short-term, high-dose pamidronate induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity Am J Kidney Dis 41 E18-221

[3] Debernardi F(1992)A review of local radiotherapy in the treatment of bone metastases and cord compression Int J Radiat Oncol Biol Phys 23 217-493

[4] Regge D(1996)Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma N Engl J Med 334 488-3

[5] Banerjee D(1999)Bisphosphonates for metastatic bone pain Support Care Cancer 7 1-485

[6] Asif A(2001)Bisphosphonates in the treatment of metastatic breast cancer J Mammary Gland Biol Neoplasia 6 477-407

[7] Striker L(2002)Bisphosphonates for cancer patients: why, how and when? Support Care Cancer 10 399-312

[8] Preston RA(2004)Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer Pain 111 306-7

[9] Bourgoignie JJ(2005)Preclinical perspectives on bisphosphonate renal safety Oncologist 10 3-1679

[10] Roth D(2003)Renal failure with the use of zoledronic acid N Engl J Med 349 1676-21

[1] Anselmetti GC(2005)Treatment of painful compression vertebral fractures with vertebroplasty: results and complications Radiol Med (Torino) 110 262-272

[2] Corgnier A(2003)Short-term, high-dose pamidronate induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity Am J Kidney Dis 41 E18-221

[3] Debernardi F(1992)A review of local radiotherapy in the treatment of bone metastases and cord compression Int J Radiat Oncol Biol Phys 23 217-493

[4] Regge D(1996)Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma N Engl J Med 334 488-3

[5] Banerjee D(1999)Bisphosphonates for metastatic bone pain Support Care Cancer 7 1-485

[6] Asif A(2001)Bisphosphonates in the treatment of metastatic breast cancer J Mammary Gland Biol Neoplasia 6 477-407

[7] Striker L(2002)Bisphosphonates for cancer patients: why, how and when? Support Care Cancer 10 399-312

[8] Preston RA(2004)Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer Pain 111 306-7

[9] Bourgoignie JJ(2005)Preclinical perspectives on bisphosphonate renal safety Oncologist 10 3-1679

[10] Roth D(2003)Renal failure with the use of zoledronic acid N Engl J Med 349 1676-21